Depot Disulfiram for AIDS and ARC
Not Applicable
Completed
- Conditions
- HIV Infections
- Registration Number
- NCT00002065
- Lead Sponsor
- St. Vincent's Medical Center
- Brief Summary
To assess the safety and efficacy of depot disulfiram as a new treatment for AIDS and AIDS related complex.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie depot disulfiram's antiretroviral activity in HIV-infected macrophages?
How does depot disulfiram compare to standard antiretroviral therapies in advanced HIV/AIDS clinical outcomes?
Which biomarkers predict therapeutic response to depot disulfiram in AIDS-related complex (ARC) patients?
What are the long-term safety profiles of depot disulfiram formulations in immunocompromised HIV populations?
Are there synergistic combination therapies involving depot disulfiram and other thiol-based HIV agents?
Trial Locations
- Locations (1)
Saint Vincent's Med Ctr
🇺🇸Staten Island, New York, United States